Japan
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.37 B
|
March 31, 2024 | USD 14.81 | -0.16% |
|
Japan |
|
2 |
USD 506.14 M
|
March 31, 2024 | USD 19.46 | -0.86% |
|
Japan |
|
3 |
USD 347.72 M
|
Dec. 31, 2023 | USD 6.50 | 1.37% |
|
Japan |
|
4 |
USD 342.37 M
|
March 31, 2024 | USD 6.77 | -0.01% |
|
Japan |
|
5 |
USD 263.93 M
|
March 31, 2024 | USD 16.64 | 0.17% |
|
Japan |
|
6 |
USD 233.99 M
|
March 31, 2024 | USD 6.73 | 0.56% |
|
Japan |
|
7 |
USD 207.94 M
|
March 31, 2024 | USD 21.79 | 1.01% |
|
Japan |
|
8 |
USD 138.37 M
|
March 31, 2024 | USD 11.29 | 0.16% |
|
Japan |
|
9 |
USD 138.30 M
|
Dec. 31, 2023 | USD 13.90 | 0.65% |
|
Japan |
|
10 |
USD 123.92 M
|
March 31, 2024 | USD 3.69 | 2.17% |
|
Japan |
|
11 |
USD 107.75 M
|
March 31, 2024 | USD 13.93 | 1.12% |
|
Japan |
|
12 |
USD 104.49 M
|
July 31, 2024 | USD 6.40 | 0.71% |
|
Japan |
|
13 |
USD 71.83 M
|
Dec. 31, 2023 | USD 9.89 | 1.42% |
|
Japan |
|
14 |
USD 70.11 M
|
March 31, 2024 | USD 11.00 | 2.12% |
|
Japan |
|
15 |
USD 56.73 M
|
March 31, 2024 | USD 11.40 | -0.74% |
|
Japan |
|
16 |
USD 56.10 M
|
July 31, 2024 | USD 2.09 | -1.87% |
|
Japan |
|
17 |
USD 47.81 M
|
March 31, 2024 | USD 18.05 | 0.49% |
|
Japan |
|
18 |
USD 47.17 M
|
Dec. 31, 2023 | USD 15.79 | 1.56% |
|
Japan |
|
19 |
USD 43.39 M
|
March 31, 2024 | USD 0.71 | -1.24% |
|
Japan |
|
20 |
USD 35.30 M
|
Sept. 30, 2024 | USD 42.86 | -1.08% |
|
Japan |
|
21 |
USD 32.36 M
|
Sept. 30, 2024 | USD 0.23 | -2.16% |
|
Japan |
|
22 |
USD 31.51 M
|
Oct. 31, 2023 | USD 5.56 | 4.96% |
|
Japan |
|
23 |
USD 30.31 M
|
Jan. 31, 2024 | USD 4.63 | -1.37% |
|
Japan |
|
24 |
USD 29.82 M
|
June 30, 2024 | USD 1.07 | -11.74% |
|
Japan |
|
25 |
USD 28.74 M
|
Dec. 31, 2023 | USD 13.03 | 1.47% |
|
Japan |
|
26 |
USD 28.26 M
|
March 31, 2024 | USD 0.91 | -1.55% |
|
Japan |
|
27 |
USD 28.19 M
|
March 31, 2024 | USD 3.21 | 0.76% |
|
Japan |
|
28 |
USD 27.45 M
|
Dec. 31, 2023 | USD 3.11 | -0.27% |
|
Japan |
|
29 |
USD 26.96 M
|
March 31, 2024 | USD 4.71 | 0.70% |
|
Japan |
|
30 |
USD 21.44 M
|
Dec. 31, 2023 | USD 6.86 | 0.18% |
|
Japan |
|
31 |
USD 20.97 M
|
March 31, 2024 | USD 7.77 | 1.66% |
|
Japan |
|
32 |
USD 20.48 M
|
Dec. 31, 2023 | USD 1.94 | -1.41% |
|
Japan |
|
33 |
USD 16.37 M
|
March 31, 2024 | USD 1.15 | -0.56% |
|
Japan |
|
34 |
USD 15.55 M
|
March 31, 2024 | USD 3.06 | -0.08% |
|
Japan |
|
35 |
USD 14.74 M
|
March 31, 2024 | USD 0.69 | -0.38% |
|
Japan |
|
36 |
USD 13.23 M
|
Dec. 31, 2023 | USD 0.76 | -4.31% |
|
Japan |
|
37 |
USD 11.92 M
|
June 30, 2024 | USD 1.52 | -0.71% |
|
Japan |
|
38 |
USD 11.41 M
|
March 31, 2024 | USD 10.02 | -1.60% |
|
Japan |
|
39 |
USD 11.14 M
|
June 30, 2024 | USD 4.18 | 0.71% |
|
Japan |
|
40 |
USD 10.86 M
|
Dec. 31, 2023 | USD 3.81 | 1.42% |
|
Japan |
|
41 |
USD 9.15 M
|
March 31, 2024 | USD 2.14 | 3.38% |
|
Japan |
|
42 |
USD 7.72 M
|
March 31, 2024 | USD 3.95 | 3.44% |
|
Japan |
|
43 |
USD 6.86 M
|
March 31, 2024 | USD 5.71 | 0.67% |
|
Japan |
|
44 |
USD 4.85 M
|
March 31, 2024 | USD 3.02 | -0.08% |
|
Japan |
|
45 |
USD 3.80 M
|
June 30, 2024 | USD 8.66 | -2.50% |
|
Japan |
|
46 |
USD 3.49 M
|
March 31, 2024 | USD 0.19 | 0.56% |
|
Japan |
The Biotechnology company in Japan with the highest Cash and Short-Term Investments is Shionogi & Co., Ltd. (Tokyo Stock Exchange: 4507.T) at USD 2.37 B.
The Biotechnology company in Japan with the lowest Cash and Short-Term Investments is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at USD 3.49 M.
The top 10 Biotechnology companies in Japan by Cash and Short-Term Investments are Shionogi & Co., Ltd., Sysmex Corporation, Nxera Pharma Co., Ltd., PHC Holdings Corporation, H.U. Group Holdings, Inc., Takara Bio Inc., Fuso Chemical Co.,Ltd., WDB Holdings Co., Ltd., PeptiDream Inc. and JCR Pharmaceuticals Co., Ltd..
The bottom 10 Biotechnology companies in Japan by Cash and Short-Term Investments are OncoTherapy Science, Inc., JTEC Corporation, Immuno-Biological Laboratories Co., Ltd., Cytori Cell Research Institute, Inc., Genetec Corporation, PhoenixBio Co., Ltd., Oncolys BioPharma Inc., Human Metabolome Technologies, Inc., Kohjin Bio Co., Ltd. and Precision System Science Co., Ltd..